Condition
Atopic Dermatitis (Eczema) clinical trials and research
As of November 12, 2026, Find a Trial lists 13 Atopic Dermatitis (Eczema) clinical trials that are recruiting, at sites in 8 countries (most in United States (4), Australia (3), Taiwan (3)). 1 was first registered in the last 30 days. By phase: Phase 2 (4), Phase 2/3 (2), Phase 3 (1), Phase 4 (1). The most active sponsors are En Chu Kong Hospital (2), Alphyn Biologics (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 13Clinical trials
- 1New in 30 days
- 8Countries
Newest Atopic Dermatitis (Eczema) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Roflumilast Cream 0.3% for moderate to severe atopic dermatitis in children, adolescents, and adults | Phase 3 | Birmingham, Alabama and 3 other locations | Recruiting | Nov 4, 2026 |
| Skin structure in atopic dermatitis patients treated with nemolizumab assessed by reflectance confocal microscopy | — | Romans-sur-Isère, Drôme | Recruiting | Jul 28, 2026 |
| Global Health Look at Atopic Dermatitis | — | Zurich | Recruiting | Jun 22, 2026 |
| cfDNA–STING pathway as a marker in atopic dermatitis | — | Nanjing, Jiangsu | Recruiting | May 7, 2026 |
| Impact of dietary salt on skin sodium and inflammatory skin disease | Phase 4 | San Francisco, California and 1 other locations | Recruiting | Mar 23, 2026 |
| Soquelitinib for adults with moderate to severe atopic dermatitis | Phase 2 | South San Francisco, California | Recruiting | Mar 2, 2026 |
| IMG-007 for adults with moderate-to-severe atopic dermatitis. | Phase 2 | Lancaster, California and 29 other locations | Recruiting | Jun 26, 2025 |
| Testing a new hydrogel for treating mild to moderate eczema | Phase 2 | Brookvale, New South Wales and 11 other locations | Recruiting | Mar 4, 2025 |
| Testing a new hydrogel for treating mild to moderate eczema | Phase 2 | Brookvale, New South Wales and 11 other locations | Recruiting | Mar 4, 2025 |
| Herbal ointment for treating atopic dermatitis | Phase 2/3 | New Taipei City | Recruiting | Feb 27, 2025 |
All recruiting trials (13)
-
Roflumilast Cream 0.3% for moderate to severe atopic dermatitis in children, adolescents, and adults
A cream called roflumilast 0.3% is tested once daily to see if it helps people with moderate to severe atopic dermatitis, compared to a non-medicated cream, across ages 6 and up.
-
Skin structure in atopic dermatitis patients treated with nemolizumab assessed by reflectance confocal microscopy
This study tests whether nemolizumab changes skin structure in adults with moderate-to-severe atopic dermatitis using a noninvasive imaging method.
-
Global Health Look at Atopic Dermatitis
A worldwide, multicenter study tests how people with atopic dermatitis access care and treat it, using data from routine medical records.
-
cfDNA–STING pathway as a marker in atopic dermatitis
This study will test whether small fragments of DNA in the blood and STING pathway activity in skin match disease severity in adults with atopic dermatitis.
-
Impact of dietary salt on skin sodium and inflammatory skin disease
We’re testing whether lowering salt and taking salt tablets changes skin sodium and symptoms in eczema and psoriasis.
-
Soquelitinib for adults with moderate to severe atopic dermatitis
This 12-week test gives adults with moderate to severe atopic dermatitis daily soquelitinib or a placebo to see if their skin and itch improve and to track side effects.
-
IMG-007 for adults with moderate-to-severe atopic dermatitis.
This study will test if different doses of IMG-007 reduce skin inflammation and itching in adults with moderate-to-severe atopic dermatitis compared with a placebo.
-
Testing a new hydrogel for treating mild to moderate eczema
This study is testing a new hydrogel called zabalafin to see if it helps people with mild to moderate eczema feel better compared to a placebo.
-
Testing a new hydrogel for treating mild to moderate eczema
This study is testing a new hydrogel called zabalafin to see if it helps people with mild to moderate eczema feel better compared to a placebo.
-
Herbal ointment for treating atopic dermatitis
This study is testing a herbal ointment made from a plant to see if it can help people with atopic dermatitis feel better.
-
Herbal ointment for treating atopic dermatitis
This study is testing a herbal ointment made from a plant to see if it can help people with atopic dermatitis feel better.
-
Effects of mulberry juice on eczema in children and adolescents
This study is testing if drinking mulberry juice can help improve eczema symptoms in children and teenagers.
-
Improving diagnosis and treatment for type 2 inflammatory skin diseases
This study is trying to improve how we diagnose and treat type 2 inflammatory skin diseases like atopic dermatitis by creating a specialized center and looking at different treatment methods to see what works best.
Related topics
Quick answers
How many Atopic Dermatitis (Eczema) clinical trials are recruiting right now?
13, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in United States (4 trials), Australia (3 trials), Taiwan (3 trials), China (2 trials), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 2/3: 2, Phase 3: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.